161 related articles for article (PubMed ID: 28413604)
1. The role of GLI1 for 5-Fu resistance in colorectal cancer.
Zhang L; Song R; Gu D; Zhang X; Yu B; Liu B; Xie J
Cell Biosci; 2017; 7():17. PubMed ID: 28413604
[TBL] [Abstract][Full Text] [Related]
2. Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer.
Song R; Gu D; Zhang L; Zhang X; Yu B; Liu B; Xie J
Mol Carcinog; 2018 Nov; 57(11):1608-1615. PubMed ID: 30074279
[TBL] [Abstract][Full Text] [Related]
3. The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer.
Yu B; Gu D; Zhang X; Liu B; Xie J
J Genet Genomics; 2017 Aug; 44(8):375-383. PubMed ID: 28847472
[TBL] [Abstract][Full Text] [Related]
4. GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer.
Yu B; Gu D; Zhang X; Li J; Liu B; Xie J
Oncotarget; 2017 Apr; 8(16):27412-27427. PubMed ID: 28404967
[TBL] [Abstract][Full Text] [Related]
5. Mouse suppressor of fused is a negative regulator of sonic hedgehog signaling and alters the subcellular distribution of Gli1.
Ding Q; Fukami Si; Meng X; Nishizaki Y; Zhang X; Sasaki H; Dlugosz A; Nakafuku M; Hui Cc
Curr Biol; 1999 Oct; 9(19):1119-22. PubMed ID: 10531011
[TBL] [Abstract][Full Text] [Related]
6. GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAF
Zhang R; Ma J; Avery JT; Sambandam V; Nguyen TH; Xu B; Suto MJ; Boohaker RJ
Front Oncol; 2020; 10():241. PubMed ID: 32185127
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple mechanisms.
Barnfield PC; Zhang X; Thanabalasingham V; Yoshida M; Hui CC
Differentiation; 2005 Oct; 73(8):397-405. PubMed ID: 16316410
[TBL] [Abstract][Full Text] [Related]
8. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma.
Yang Z; Zhang C; Qi W; Cui Y; Xuan Y
Exp Cell Res; 2018 Dec; 373(1-2):145-154. PubMed ID: 30321514
[TBL] [Abstract][Full Text] [Related]
9. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells.
Wen S; Wang X; Wang Y; Shen J; Pu J; Liang H; Chen C; Liu L; Dai P
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):896-905. PubMed ID: 29475390
[TBL] [Abstract][Full Text] [Related]
11. Novel proapoptotic agent SM-1 enhances the inhibitory effect of 5-fluorouracil on colorectal cancer cells
Wang Y; Yuan S; Li L; Yang D; Xu C; Wang S; Zhang D
Oncol Lett; 2017 Jun; 13(6):4762-4768. PubMed ID: 28599477
[TBL] [Abstract][Full Text] [Related]
12. MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFβR2.
Liu J; Huang Y; Wang H; Wu D
Int J Clin Exp Pathol; 2018; 11(12):5622-5634. PubMed ID: 31949649
[TBL] [Abstract][Full Text] [Related]
13. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
[TBL] [Abstract][Full Text] [Related]
14. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
[TBL] [Abstract][Full Text] [Related]
15. Induction of resistance to oxaliplatin in cancer by a microRNA/Fem1B/Gli1 pathway.
Su YC; Metzen LT; Vélez LM; Bournique E; Seldin M; Buisson R; Kuo WW; Huang CY; Kaiser P
Am J Cancer Res; 2023; 13(12):6011-6025. PubMed ID: 38187042
[TBL] [Abstract][Full Text] [Related]
16. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
[TBL] [Abstract][Full Text] [Related]
17. Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer.
Douard R; Moutereau S; Pernet P; Chimingqi M; Allory Y; Manivet P; Conti M; Vaubourdolle M; Cugnenc PH; Loric S
Surgery; 2006 May; 139(5):665-70. PubMed ID: 16701100
[TBL] [Abstract][Full Text] [Related]
18. Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer.
Griffith M; Mwenifumbo JC; Cheung PY; Paul JE; Pugh TJ; Tang MJ; Chittaranjan S; Morin RD; Asano JK; Ally AA; Miao L; Lee A; Chan SY; Taylor G; Severson T; Hou YC; Griffith OL; Cheng GS; Novik K; Moore R; Luk M; Owen D; Brown CJ; Morin GB; Gill S; Tai IT; Marra MA
Pharmacogenomics J; 2013 Apr; 13(2):148-58. PubMed ID: 22249354
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of miR-197-3p in colorectal cancer.
Wang M; Hu H; Wang Y; Huang Q; Huang R; Chen Y; Ma T; Qiao T; Zhang Q; Wu H; Chen Q; Han D; Wang G; Wang X
J Cancer; 2019; 10(19):4603-4613. PubMed ID: 31528224
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids.
Sabeti Aghabozorgi A; Moradi Sarabi M; Jafarzadeh-Esfehani R; Koochakkhani S; Hassanzadeh M; Kavousipour S; Eftekhar E
World J Gastrointest Oncol; 2020 Sep; 12(9):942-956. PubMed ID: 33005290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
